Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy.

Diabetes research and clinical practice·2026
Same author

Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study.

Journal of clinical medicine·2026
Same author

Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma.

Proteomics·2026
Same author

Fibromuscular Dysplasia: Emerging Concepts Beyond the International Consensus.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.

Proteomics·2026
Same author

Urinary Collagen Peptides Predict Mortality.

Proteomics·2026
Same journal

Adsorption of Pathogens and Blockade of Sepsis Cascade.

Contributions to nephrology·2023
Same journal

Hemoadsorption: Research Agenda and Potential Future Applications.

Contributions to nephrology·2023
Same journal

Hemoperfusion in Poisoning and Drug Overdose.

Contributions to nephrology·2023
Same journal

Hemoperfusion in Burns.

Contributions to nephrology·2023
Same journal

Sequential Extracorporeal Therapy in Sepsis.

Contributions to nephrology·2023
Same journal

The Use of Adsorption in Extracorporeal Liver Support: The Double Plasma Molecular Adsorption System (DPMAS).

Contributions to nephrology·2023
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
14:48

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis

Published on: May 8, 2021

Exploring the uremic toxins using proteomic technologies.

Eric Schiffer1, Harald Mischak, Raymond C Vanholder

  • 1Mosaiques Diagnostics & Therapeutics, Hanover, Germany.

Contributions to Nephrology
|April 11, 2008
PubMed
Summary
This summary is machine-generated.

Proteomics, including capillary electrophoresis coupled to mass spectrometry (CE-MS), offers advanced methods for identifying uremic toxins. These novel biomarkers are crucial for understanding kidney failure and developing new diagnostics.

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Related Experiment Videos

Last Updated: Jul 6, 2026

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
14:48

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis

Published on: May 8, 2021

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Area of Science:

  • Biochemistry
  • Nephrology
  • Analytical Chemistry

Background:

  • Kidney failure causes uremic syndrome due to the accumulation of toxic substances normally cleared by the kidneys.
  • Polypeptides are a significant, heterogeneous group of these uremic toxins.
  • Identifying and characterizing these toxins is vital for understanding disease progression.

Purpose of the Study:

  • To provide an overview of proteomic technologies for detecting uremic toxins.
  • To highlight the capabilities of capillary electrophoresis coupled to mass spectrometry (CE-MS) in this field.
  • To discuss the application of proteomics in identifying novel biomarkers for renal diseases.

Main Methods:

  • Proteomic analysis, including classical techniques like 2D gel electrophoresis and mass spectrometry for larger polypeptides (>10 kDa).
  • Capillary electrophoresis coupled to mass spectrometry (CE-MS) for analyzing smaller polypeptides (1-10 kDa), capable of analyzing up to 1,400 compounds.
  • Review of proteomic applications in biomarker discovery for renal diseases.

Main Results:

  • Proteomic technologies are effective tools for detecting a wide range of uremic toxins.
  • CE-MS is a rapid and powerful method for analyzing medium-sized polypeptides in uremic samples.
  • Proteomic approaches have successfully identified novel biomarkers associated with renal diseases.

Conclusions:

  • Proteomics offers promising avenues for identifying new uremic toxins and biomarkers.
  • CE-MS is particularly valuable for the analysis of medium-sized polypeptides in uremic syndrome.
  • These advancements in proteomic analysis are crucial for improving the diagnosis and understanding of kidney failure.